Welcome to our dedicated page for Anterix news (Ticker: $ATEX), a resource for investors and traders seeking the latest updates and insights on Anterix stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Anterix's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Anterix's position in the market.
Anterix (NASDAQ: ATEX) will present at upcoming investor conferences in May 2024, including Sidoti, J.P. Morgan, and B. Riley. The company's CFO will participate in fireside chats and one-on-one meetings to engage with interested investors. The presentations will be accessible via live webcasts on the Anterix Investor Relations event website.
Anterix (NASDAQ: ATEX) is collaborating with EPRI, George Mason University, Southern Company, and Virginia Tech to explore cybersecurity technologies for critical energy infrastructure. The project, STAR TREC, aims to reduce cybersecurity risks by applying standards architectures.